Jill Magnus

Biochemistry, Genetics and Molecular Biology · Life Sciences

5h-index3.4kcitations17works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(16), Circular RNAs in diseases(11), Liver Disease Diagnosis and Treatment(4), RNA modifications and cancer(4), Ferroptosis and cancer prognosis(2)

Publications17 total

Supplementary Figure 4S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Data from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 2S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 3S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 2S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 1S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 1S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 4S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Methods and legends from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Data from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Methods and legends from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 3S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
Molecular Cancer Therapeutics·2017· 21 cited
Reduced seed region-based off-target activity with lentivirus-mediated RNAi
RNA·2010· 24 citedOpen Access
microRNAs regulate human embryonic stem cell division
Cell Cycle·2009· 160 citedOpen Access
MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
Molecular and Cellular Biology·2008· 554 cited
A microRNA component of the p53 tumour suppressor network
Nature·2007· 2.7k citedOpen Access

Frequent Co-authors

Xinqiang Huang(13), Vivek Kaimal(13), Priya Karmali(13), Marlena Walls(13), Rene Prudente(13), Eric Sung(13), Mehran Sorourian(13), Heather Estrella(13), Edmund C. Lee(13), Adam Pavlı́c̀ek(13), Sonya Zabludoff(13), Scott Davis(12), Xia Yang(12), B. Nelson Chau(12), Robin Lee(11), Jian Li(10), Michele A. Cleary(4), Lee P. Lim(3), Aimee L. Jackson(2), Peter S. Linsley(2)